Acute Fatty Liver of Pregnancy (AFLP) and Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) syndrome are rare but life-threatening liver disorders that can occur during pregnancy. While both conditions share similarities, they have distinct causes, complications, and management approaches.
Understanding their differences is essential for appropriate early diagnosis and intervention to prevent maternal and fetal complications.
AFLP and HELLP syndrome can present with overlapping symptoms, such as nausea, vomiting, abdominal pain, and jaundice. However, they differ significantly in their underlying mechanisms and diagnostic criteria.
HELLP syndrome directly impacts liver function by causing widespread endothelial dysfunction, leading to increased liver enzyme levels and hepatocellular necrosis.
The damage to liver cells can result in subcapsular hematomas and, in severe cases, liver rupture.
Additionally, the reduced platelet count and clotting abnormalities increase the risk of internal bleeding, which can be life-threatening if not treated immediately.
AFLP can result in multi-organ failure when not recognized early. Some of the most severe complications include:
Although these conditions are rare, some factors may elevate the risk.
For AFLP, risk factors include genetic defects in fatty acid oxidation (e.g., LCHAD deficiency), multiple pregnancies, previous history of AFLP, and male fetal sex.
HELLP syndrome is most commonly associated with preeclampsia, chronic hypertension, maternal age over 35, and a history of HELLP in previous pregnancies.
Early detection is crucial to prevent severe complications. Diagnosis involves:
Both AFLP and HELLP require immediate medical care.
For AFLP, immediate delivery is the primary treatment. Supportive care includes IV fluids, glucose supplementation, and monitoring for organ failure.
In HELLP syndrome, delivery is also the definitive treatment, often requiring steroid therapy to promote fetal lung development if premature delivery is necessary. Blood transfusions and magnesium sulfate may be needed to manage complications.